Turn down the heat.

Headline: HIPEC doesn’t actually work. The French PRODIGE 7 trial with the first to test in a randomized fashion the benefit of hyperthermic intraperitoneal chemo (HIPEC) with oxaliplatin for the management of carcinomatosis from colorectal cancer. The primary endpoint of overall survival was the same whether or not HIPEC was added to cytoreductive surgery (41-42 months). Bottom Line: The headline says it all. | Quenet, ASCO 2017